This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
這位Alumis分析師以看好的態度開始覆蓋；以下是週四的五個重點啓動
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
華爾街頂級分析師改變了對這些頂級公司的展望。如需查看包括升級和降級在內的所有分析師評級變化的完整視圖，請參閱我們的分析師評級頁面。
- Baird analyst Brian Skorney initiated coverage on Alumis Inc. (NASDAQ:ALMS) with an Outperform rating and announced a price target of $25. Alumis shares closed at $11.23 on Wednesday. See how other analysts view this stock.
- Jones Trading analyst Soumit Roy initiated coverage on Enliven Therapeutics, Inc. (NASDAQ:ELVN) with a Buy rating and announced a price target of $36. Enliven Therapeutics shares closed at $28.39 on Wednesday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Swayampakula Ramakanth initiated coverage on Intensity Therapeutics, Inc. (NASDAQ:INTS) with a Buy rating and announced a price target of $5. Intensity Therapeutics shares closed at $3.05 on Wednesday. See how other analysts view this stock.
- Oppenheimer analyst Jay Olson initiated coverage on Terns Pharmaceuticals, Inc. (NASDAQ:TERN) with an Outperform rating and announced a price target of $17. Terns Pharma shares closed at $6.89 on Wednesday. See how other analysts view this stock.
- Macquarie initiated coverage on Braze, Inc. (NASDAQ:BRZE) with a Neutral rating and announced a price target of $30. Braze shares closed at $32.00 on Wednesday. See how other analysts view this stock.
- Baird分析師Brian Skorney首次對Alumis Inc.（納斯達克：ALMS）進行覆蓋，給予超額評級，並公佈了25美元的目標股價。Alumis股價週三收於11.23美元。看看其他分析師如何看待這支股票。
- Jones Trading分析師Soumit Roy首次對Enliven Therapeutics, Inc.（納斯達克：ELVN）進行覆蓋，給予買入評級，並公佈了36美元的目標股價。Enliven Therapeutics股價週三收於28.39美元。看看其他分析師如何看待這支股票。
- HC Wainwright & Co.分析師Swayampakula Ramakanth首次對Intensity Therapeutics, Inc.（納斯達克：INTS）進行覆蓋，給予買入評級，並公佈了5美元的目標股價。Intensity Therapeutics股價週三收於3.05美元。看看其他分析師如何看待這支股票。
- Oppenheimer分析師Jay Olson首次對Terns Pharmaceuticals, Inc.（納斯達克：TERN）進行覆蓋，給予超額評級，並公佈了17美元的目標股價。Terns Pharma股價週三收於6.89美元。看看其他分析師如何看待這支股票。
- Macquarie首次對Braze, Inc.（納斯達克：BRZE）進行覆蓋，給予中立評級，並公佈了30美元的目標股價。Braze股價週三收於32.00美元。看看其他分析師如何看待這支股票。
Considering buying ALMS stock? Here's what analysts think:
考慮買入ALMS股票嗎？這是分析師們的看法：
Read More:
閱讀更多：
- Wall Street's Most Accurate Analysts Weigh In On 3 Energy Stocks With Over 8% Dividend Yields
- 華爾街最準確的分析師就三家能源股票的8%以上股息率發表意見
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間